Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients

Internal and Emergency Medicine

Volumn 3, Issue 2, 2008, Pages 117-122

  Verso, Melina ^a   Agnelli, Giancarlo ^a   Kamphuisen, Pieter W ^a,b   Ageno, Walter ^c   Bazzan, Mario ^d   Lazzaro, Antonio ^e   Paoletti, Francesco ^a   Paciaroni, Maurizio ^a   Mosca, Stefano ^a   Bertoglio, Sergio ^f  

^a UNIVERSITY OF PERUGIA   (Italy)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF INSUBRIA   (Italy)

^d Ospedale Evangelico Valdese   (Italy)

^e AUSL di Piacenza   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

Author keywords

Cancer; Central vein catheter; Risk factors for thrombosis; Upper limb DVT; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; ENOXAPARIN; FIBRINOLYTIC AGENT;

ARM; ARTICLE; CENTRAL VENOUS CATHETERIZATION; CONFIDENCE INTERVAL; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INDWELLING CATHETER; MALE; MIDDLE AGED; NEOPLASM; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TREATMENT OUTCOME; VEIN THROMBOSIS;

ANTICOAGULANTS; ANTINEOPLASTIC AGENTS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CONFIDENCE INTERVALS; DOUBLE-BLIND METHOD; ENOXAPARIN; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASMS; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; UPPER EXTREMITY; VENOUS THROMBOSIS;

EID: 43749086865     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-008-0125-3     Document Type: Article

References (27)

1. Agnelli G, Verso M (2006) Therapy insight: venous catheter-related thrombosis in cancer patients. Nat Clin Pract Oncol 3(4):214-222
2. Agnelli G, Verso M (2005) Thrombosis and cancer: clinical relevance of a dangerous liaison. Haematologica 90(2):154-156
3. Verso M, Agnelli G (2003) Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 21:3665-3675
4. Bern HM, Lokich JJ, Wallach SR et al (1990) Very low dose of warfarin can prevent thrombosis in central venous catheters: a randomized, prospective trial. Ann Inter Med 112:423-428
5. Monreal M, Alastrue A, Rull M et al (1996) Upper extremity deep venous thrombosis in cancer patients with venous access devices. Prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 75:251-253
6. Karthaus M, Kretzschmar A, Kröning H et al (2006) A Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Ann Oncol 17(2):289-296
7. Couban S, Goodyear M, Burnell M et al (2005) Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol 23(18):4063-4069
8. Geerts WH, Pineo GF, Heit JA et al (2004) Prevention of venous thromboembolism. Chest 126:338S-400S
9. Young AM, Begum G, Billingham LJ (2005) WARP-a multicentre, prospective, randomized controlled trial of thrombosis prophylaxis with warfarin in cancer patients with central venous catheters (CVCs). Ann ASCO Meet 2005; abstr no. 8004
10. Verso M, Agnelli G, Bertoglio S et al (2005) Enoxaparin for the prevention of venous thromboembolism associated with central vein catheters: a double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol 23(18):4057-4062
11. Cadman A, Lawrance JAL, Fitzsimmons L, Spencer-Shaw A, Swindell R (2004) To clot or not to clot? That is the question in central venous catheters? Clin Rad 59:349-355
12. Tesselaar ME, Ouwerkek J, Nooy MA, Rosendaal FR, Osanto S (2004) Risk factors for catheter-related thrombosis in cancer patients. Eur J Cancer 40:2253-2259
13. Eastridge BJ, Lefor AT (1995) Complication of indwelling venous access devices in cancer patients. J Clin Onc 13(1):233-238
14. Timsit JF, Farkas JC, Boyer JM et al (1998) Central vein catheter-related thrombosis in intensive care patients. Incidence, risk factors and relationship with catheter-related sepsis. Chest 114:207-213
15. Craft PS, May J, Dorigo A, Hoy C, Plant A (1996) Hickman catheters: left sided insertion, male gender and obesity are associated with an increased risk of complications. Aust NZ J Med 26:33-39
16. Unal AE, Bayar S, Arat M, Ihhan O (2003) Malpositioning of Hickman catheters, left versus right sided attempts. Transfus Apheresis Sci 28:9-12
17. PetersenJ, Delaney JH, Brakstad MT, Rowbotham RK, Bagley CM (1999) Silicone venous access devices positioned with their tips high in the superior vena cava are more likely to malfunction. Am J Surg 178(1):38-41
18. McGee WT, Ackerman BL, Rouben LR, Prasad VM, Bandi V, Mallory DL (1993) Accurate placement of central venous catheters: a prospective, randomized, multicenter trial. Crit Care Med 21(8):1118-1123
19. Puel V, Caudry M, Metayer P et al (1993) Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports. Cancer 72:2248-2252
20. Agnelli G, Verso M (2006) Is antithrombotic prophylaxis required in cancer patients with central venous catheters? No. J Thromb Haemost 4(1):14-15
21. Luciani A, Clement O, Halimi P et al (2001) Catheter-related upper extremity deep venous thrombosis in cancer patients: a prospective study based on doppler US. Radiology 220(3):655-660
22. Kearns PJ, Coleman S, Wehner JH (1996) Complications of long-term catheters: randomized trial of central vs. peripheral tip location. J PEN 20(1):20-24
23. Gould JR, Carloss HW, Skinner WL (1993) Groshong catheter-associated subclavian venous thrombosis. Am J Med 95(4):419-423
24. De Cicco M, Matovic M, Balestrieri L et al (1997) Central venous thrombosis: an early and frequent complication in cancer patients bearing long term silastic catheter. A prospective study. Thromb Res 86(2):101-113
25. Blom JW, Doggen CJM, Osanto S, Rosendaal FR (2005) Malignancies, prothrombotic mutations and the risk of venous thrombosis. JAMA 293:715-722
26. Randolph AG, Cook DJ, Gonzales CA, Andrew M (1998) Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest 113(1):165-171
27. Stephens LC, Haire WD, Tarantolo S et al (1997) Normal saline versus heparin flush for maintaining central venous catheter patency during apheresis collection of peripheral blood stem cell. Transfus Sci 18(2):187-193